MedPath

Clinical Validation of a Smart Wearable Device to Monitor Cardiac and Respiratory Vital Signs using Morphic Band Sensors ASPEN Trial”

Not Applicable
Conditions
Cardiac Vital Sign
Respiratory Vital Signs
Cardiovascular - Other cardiovascular diseases
Respiratory - Other respiratory disorders / diseases
Registration Number
ACTRN12621000028808
Lead Sponsor
Medical Monitoring Solutions Pty Ltd
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
ot yet recruiting
Sex
All
Target Recruitment
82
Inclusion Criteria

1.Healthy Volunteers must have given written informed consent before any study related activities are carried out and must be able to understand the full nature and purpose of the trial including possible risks. Ventilated participants will not be consented however patient’s Person Responsible will be informed of the study and asked to provide consent.
2.Female participants of childbearing potential must not be pregnant or nursing at the time of enrolment.
3.Must be able to be fitted with the device.
4.Provision of use of a Smart phone for the duration of the study, and willingness to download the App for at-home study.
5. If a Healthy participants who consent to the at-home study must be willing to use personal WIFI for App use and phone which has Bluetooth.
6.If in ICU arm admitted for ventilatory support using invasive ventilation as part of standard of care.

Exclusion Criteria

1.Known skin sensitivities or allergies to elasticated products.
2.Broken skin or rashes on torso (where devices will be in contact with the skin).
3.Participant who, in the opinion of the investigator, is not a good candidate for the study.
4.Cardiac pacemaker or implantable defibrillator, known to require defibrillation.
5.Any medical intervention that would interfere with the study.
6.Participant with surgical wounds/dressing precluding the appropriate placement of the investigational device.

Study & Design

Study Type
Observational
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Respiratory rate (RR) breaths per minute from investigational device compared to gold standard output.[Day 1 and Day 14.];Temperature (skin) in degrees Celsius from investigational device compared to gold standard output.[Day 1 and Day 14.];Heart Rate (HR) beats per minute from investigational device compared to gold standard output.[Day 1 and Day 14.]
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath